Cargando…

Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study

BACKGROUND: The prevalence of the metabolic syndrome (MS) has been determined in many countries worldwide but never in Luxembourg. This research aimed to 1) establish the gender- and age-specific prevalence of MS and its components in the general adult population of Luxembourg, according to the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkerwi, Ala'a, Donneau, Anne-Françoise, Sauvageot, Nicolas, Lair, Marie-Lise, Scheen, André, Albert, Adelin, Guillaume, Michèle
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024931/
https://www.ncbi.nlm.nih.gov/pubmed/21205296
http://dx.doi.org/10.1186/1471-2458-11-4
_version_ 1782196835760209920
author Alkerwi, Ala'a
Donneau, Anne-Françoise
Sauvageot, Nicolas
Lair, Marie-Lise
Scheen, André
Albert, Adelin
Guillaume, Michèle
author_facet Alkerwi, Ala'a
Donneau, Anne-Françoise
Sauvageot, Nicolas
Lair, Marie-Lise
Scheen, André
Albert, Adelin
Guillaume, Michèle
author_sort Alkerwi, Ala'a
collection PubMed
description BACKGROUND: The prevalence of the metabolic syndrome (MS) has been determined in many countries worldwide but never in Luxembourg. This research aimed to 1) establish the gender- and age-specific prevalence of MS and its components in the general adult population of Luxembourg, according to the most recent Joint Interim Statement (JIS) definition, by using both the high and low cut-off points to define abdominal obesity, and 2) compare and assess the degree of agreement with the Revised National Cholesterol Education Programme-Adult Treatment Panel III (R-ATPIII) and the International Diabetes Federation (IDF) definitions. METHODS: A representative stratified random sample of 1349 European subjects, aged 18-69 years, participated to ORISCAV-LUX survey. Logistic regression and odds ratios (OR) were used to study MS prevalence with respect to gender and age. The Framingham risk score (FRS) to predict the 10-year coronary heart disease (CHD) risk was calculated to compare the proportion of MS cases below or above 20%, according to both high and low waist circumference (WC) thresholds. Cohen's kappa coefficient (κ) was utilized to measure the degree of agreement between MS definitions. RESULTS: The prevalence of the MS defined by the JIS was 28.0% and 24.7% when using the low (94/80) and the high (102/88) WC cut-off points, respectively. The prevalence was significantly higher in men than in women (OR = 2.6 and 2.3 for the low and high WC thresholds), as were all components of the MS except abdominal obesity measured by both thresholds. It also increased with age (OR values in age categories ranging from 2.7 to 28 when compared to the younger subjects for low WC and from 3.3 to 31 for the high WC cut-offs). The 10-year predicted risk of CHD by FRS did not depend on the threshold used. Globally, excellent agreement was observed between the three definitions of MS (κ= 0.89), in particular between JIS and IDF (κ = 0.93). Agreement was significantly higher in women than in men, and differed between age groups. CONCLUSION: Regardless of the definition used, the adult population of Luxembourg reveals a high MS prevalence. Our findings contribute to build evidence regarding the definitive construct of the MS, to help selecting the waist circumference thresholds for Europid populations, and to support the need to revise the guidelines for abdominal obesity levels.
format Text
id pubmed-3024931
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30249312011-01-22 Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study Alkerwi, Ala'a Donneau, Anne-Françoise Sauvageot, Nicolas Lair, Marie-Lise Scheen, André Albert, Adelin Guillaume, Michèle BMC Public Health Research Article BACKGROUND: The prevalence of the metabolic syndrome (MS) has been determined in many countries worldwide but never in Luxembourg. This research aimed to 1) establish the gender- and age-specific prevalence of MS and its components in the general adult population of Luxembourg, according to the most recent Joint Interim Statement (JIS) definition, by using both the high and low cut-off points to define abdominal obesity, and 2) compare and assess the degree of agreement with the Revised National Cholesterol Education Programme-Adult Treatment Panel III (R-ATPIII) and the International Diabetes Federation (IDF) definitions. METHODS: A representative stratified random sample of 1349 European subjects, aged 18-69 years, participated to ORISCAV-LUX survey. Logistic regression and odds ratios (OR) were used to study MS prevalence with respect to gender and age. The Framingham risk score (FRS) to predict the 10-year coronary heart disease (CHD) risk was calculated to compare the proportion of MS cases below or above 20%, according to both high and low waist circumference (WC) thresholds. Cohen's kappa coefficient (κ) was utilized to measure the degree of agreement between MS definitions. RESULTS: The prevalence of the MS defined by the JIS was 28.0% and 24.7% when using the low (94/80) and the high (102/88) WC cut-off points, respectively. The prevalence was significantly higher in men than in women (OR = 2.6 and 2.3 for the low and high WC thresholds), as were all components of the MS except abdominal obesity measured by both thresholds. It also increased with age (OR values in age categories ranging from 2.7 to 28 when compared to the younger subjects for low WC and from 3.3 to 31 for the high WC cut-offs). The 10-year predicted risk of CHD by FRS did not depend on the threshold used. Globally, excellent agreement was observed between the three definitions of MS (κ= 0.89), in particular between JIS and IDF (κ = 0.93). Agreement was significantly higher in women than in men, and differed between age groups. CONCLUSION: Regardless of the definition used, the adult population of Luxembourg reveals a high MS prevalence. Our findings contribute to build evidence regarding the definitive construct of the MS, to help selecting the waist circumference thresholds for Europid populations, and to support the need to revise the guidelines for abdominal obesity levels. BioMed Central 2011-01-04 /pmc/articles/PMC3024931/ /pubmed/21205296 http://dx.doi.org/10.1186/1471-2458-11-4 Text en Copyright ©2011 Alkerwi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Alkerwi, Ala'a
Donneau, Anne-Françoise
Sauvageot, Nicolas
Lair, Marie-Lise
Scheen, André
Albert, Adelin
Guillaume, Michèle
Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
title Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
title_full Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
title_fullStr Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
title_full_unstemmed Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
title_short Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study
title_sort prevalence of the metabolic syndrome in luxembourg according to the joint interim statement definition estimated from the oriscav-lux study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024931/
https://www.ncbi.nlm.nih.gov/pubmed/21205296
http://dx.doi.org/10.1186/1471-2458-11-4
work_keys_str_mv AT alkerwialaa prevalenceofthemetabolicsyndromeinluxembourgaccordingtothejointinterimstatementdefinitionestimatedfromtheoriscavluxstudy
AT donneauannefrancoise prevalenceofthemetabolicsyndromeinluxembourgaccordingtothejointinterimstatementdefinitionestimatedfromtheoriscavluxstudy
AT sauvageotnicolas prevalenceofthemetabolicsyndromeinluxembourgaccordingtothejointinterimstatementdefinitionestimatedfromtheoriscavluxstudy
AT lairmarielise prevalenceofthemetabolicsyndromeinluxembourgaccordingtothejointinterimstatementdefinitionestimatedfromtheoriscavluxstudy
AT scheenandre prevalenceofthemetabolicsyndromeinluxembourgaccordingtothejointinterimstatementdefinitionestimatedfromtheoriscavluxstudy
AT albertadelin prevalenceofthemetabolicsyndromeinluxembourgaccordingtothejointinterimstatementdefinitionestimatedfromtheoriscavluxstudy
AT guillaumemichele prevalenceofthemetabolicsyndromeinluxembourgaccordingtothejointinterimstatementdefinitionestimatedfromtheoriscavluxstudy